
RosettaPath helps life science teams make safer, more effective medicines through pathology expertise. It uses experimental, translational, and toxicologic pathology with digital pathology and image-analysis AI tools to analyze slides and whole-slide images. The company targets biotech, pharmaceutical firms, CROs, AI vendors, and academia as clients. Services include peer review, outsourced project pathologist roles, primary microscopic examination and interpretation, and regulatory input on pathology questions. It focuses on risk assessment and supports product registration with data-driven insights.

RosettaPath helps life science teams make safer, more effective medicines through pathology expertise. It uses experimental, translational, and toxicologic pathology with digital pathology and image-analysis AI tools to analyze slides and whole-slide images. The company targets biotech, pharmaceutical firms, CROs, AI vendors, and academia as clients. Services include peer review, outsourced project pathologist roles, primary microscopic examination and interpretation, and regulatory input on pathology questions. It focuses on risk assessment and supports product registration with data-driven insights.